G1 Therapeutics.

PositionStatewide: TRIANGLE REGION

DURHAM -- G1 Therapeutics raised $33 million in a round of financing led by Eshelman Ventures, a Wilmington-based investment company started by Pharmaceutical Product Development founder Fred Eshelman, and Boston-based RA Capital Management. The...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT